{"symbol":"BSX","fiscalQuarter":"Q3-2018","reportDate":"2018-10-24","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2018","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Down 0.97%","keyNumbers":[{"metric":"EPS","actual":"$0.35","expected":"N/A","surprise":"-1.07%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation.","They noted challenges in certain markets but remain focused on long-term growth."],"summary":"Management expressed a cautious optimism regarding future growth despite current market challenges. They emphasized their commitment to innovation and strategic investments."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a slight miss on EPS, which contributed to a 0.97% decline in stock price. The lack of revenue data and guidance may have raised concerns among investors. Management's cautious tone reflects ongoing challenges but a commitment to future growth through innovation.","metaDescription":"Boston Scientific (BSX) Q3 2018 earnings: EPS missed. Stock down 0.97%. Full breakdown."}}